Genomics, Inc. , a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with single-cell ...
For the first time, a research team at the Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) has succeeded in ...
Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies. But ...
Takara Bio USA, Inc. today announced the launch of its CSP Program and announced the certification of Admera Health on the ...
In 2011, The Scientist featured Bergmann’s early work on stomata development. She now uses new omics tools to explore the ...
As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...
Cell-based assay innovation is reshaping how we discover, validate, and de-risk therapeutic candidates across disease areas. This Research Topic invites ...
This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...
AWS Social Impact and Sustainability Program awards Admera Health, Bringing Next-Generation Genomics to Underserved ...
MGI Tech marks a decade of progress in genomics, highlighting key technology milestones that have accelerated life science ...
Inflammation research sits at the intersection of immunology, systems biology, and molecular medicine, focusing on the cellular and molecular mechanisms ...
Researchers from The University of Texas MD Anderson Cancer Center will present breakthrough studies at the American Association for Cancer Research (AACR) Annual Meeting 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results